ARTICLE | Clinical News
Gene Activation Technology regulatory update
January 31, 2000 8:00 AM UTC
ARIA received U.S. Patent No. 6,015,709 covering a class of recombinant gene activator proteins used in its Gene Activation Technology, which activates endogenous and engineered genes with engineered ...